Charles Schwab Investment Management Inc Volitionrx LTD Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Volitionrx LTD stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 15,384 shares of VNRX stock, worth $9,384. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,384
Previous 15,384
-0.0%
Holding current value
$9,384
Previous $11,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VNRX
# of Institutions
27Shares Held
7.96MCall Options Held
39KPut Options Held
0-
Lagoda Investment Management, L.P. New York, NY5.07MShares$3.09 Million2.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA636KShares$388,0610.0% of portfolio
-
Geode Capital Management, LLC Boston, MA617KShares$376,5930.0% of portfolio
-
Black Rock Inc. New York, NY574KShares$349,9930.0% of portfolio
-
Cowen Prime Advisors LLC179KShares$109,0300.09% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $35M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...